Legend Biotech Files 6-K Report
Ticker: LEGN · Form: 6-K · Filed: Apr 14, 2026
Sentiment: neutral
Topics: regulatory-filing, corporate-update
TL;DR
Legend Biotech filed a 6-K on 4/14/26 - standard corporate update.
AI Summary
Legend Biotech Corp. filed a Form 6-K on April 14, 2026, reporting information as a foreign issuer. The filing includes standard corporate information such as mailing and business addresses in Somerset, NJ, and identifies the company's CIK as 0001801198. The report is categorized under Pharmaceutical Preparations.
Why It Matters
This filing provides routine corporate updates for Legend Biotech, which is relevant for investors tracking the company's regulatory and administrative disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign issuer and does not contain significant financial or operational news.
Key Players & Entities
- Legend Biotech Corp. (company) — Filer
- 0001801198 (company) — CIK
- 2026-04-14 (date) — Filing Date
- 2101 COTTONTAIL LANE SOMERSET NJ 08873 (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is a Form 6-K, a Report of foreign issuer.
When was this filing made?
The filing date was April 14, 2026.
What is the CIK number for Legend Biotech Corp.?
The CIK number for Legend Biotech Corp. is 0001801198.
Where are Legend Biotech's business and mailing addresses located?
Both the business and mailing addresses are listed as 2101 COTTONTAIL LANE SOMERSET NJ 08873.
What industry is Legend Biotech Corp. categorized under?
Legend Biotech Corp. is categorized under SIC code 2834, Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2026 regarding Legend Biotech Corp (LEGN).